Compare XENE & MGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XENE | MGY |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.8B |
| IPO Year | 2014 | 2017 |
| Metric | XENE | MGY |
|---|---|---|
| Price | $65.42 | $25.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 15 |
| Target Price | ★ $68.55 | $30.36 |
| AVG Volume (30 Days) | 1.5M | ★ 5.6M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | $311,000.00 | ★ $1,311,845,000.00 |
| Revenue This Year | N/A | $14.65 |
| Revenue Next Year | $2,496.48 | $1.99 |
| P/E Ratio | ★ N/A | $107.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $30.00 | $21.07 |
| 52 Week High | $72.66 | $32.76 |
| Indicator | XENE | MGY |
|---|---|---|
| Relative Strength Index (RSI) | 57.04 | 42.11 |
| Support Level | $52.40 | $25.24 |
| Resistance Level | $72.66 | $27.86 |
| Average True Range (ATR) | 2.72 | 0.86 |
| MACD | -0.51 | -0.00 |
| Stochastic Oscillator | 39.18 | 37.81 |
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Magnolia Oil & Gas Corp is an independent oil and natural gas company engaged in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids (NGL) reserves. The company's oil and natural gas properties are located in Karnes County and the Giddings area of South Texas, where it targets the Eagle Ford Shale and Austin Chalk formations. It focuses on generating value for shareholders by delivering steady, moderate annual production growth resulting from its capital spending philosophy. The company operates in only one segment and derives the majority of its revenue from the sale of crude oil, natural gas, and natural gas liquids (NGLs).